Literature DB >> 31668207

Nanotechnology in Radiation Oncology.

Bo Sun1, C Tilden Hagan2, Joseph Caster3, Andrew Z Wang4.   

Abstract

Nanotechnology has made remarkable contributions to clinical oncology. Nanotherapeutics and diagnostic tools have distinctive characteristics which allow them superior abilities to deliver therapeutics and imaging agents for radiation oncology. Compared to solid biopsies and imaging, the analysis of circulating tumor cells (CTCs) offers a more rapid, real-time, and less invasive method to monitor the dynamic molecular profiles of tumors. The potential of CTCs to be translated as a novel cancer biomarker has been demonstrated in numerous clinical studies. This review will discuss clinical applications of nanomaterials in radiation oncology and the implication of CTCs in cancer detection and monitoring.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer biomarkers; Circulating tumor DNA; Circulating tumor cells; Liquid biopsy; Nanoparticles; Radiosensitization; Radiotherapy; Tumor imaging

Mesh：

Substances：

Year:  2019        PMID： 31668207      PMCID： PMC6981287          DOI： 10.1016/j.hoc.2019.08.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  111 in total

Review 1.  Challenges in circulating tumour cell research.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2014-07-31       Impact factor: 60.716

2.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

Authors:  Miriam Benezra; Oula Penate-Medina; Pat B Zanzonico; David Schaer; Hooisweng Ow; Andrew Burns; Elisa DeStanchina; Valerie Longo; Erik Herz; Srikant Iyer; Jedd Wolchok; Steven M Larson; Ulrich Wiesner; Michelle S Bradbury
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Authors:  Hanna K Sanoff; Dominic H Moon; Dominic T Moore; Jeremiah Boles; Courtney Bui; William Blackstock; Bert H O'Neil; Somasundaram Subramaniam; Autumn J McRee; Cheryl Carlson; Michael S Lee; Joel E Tepper; Andrew Z Wang
Journal:  Nanomedicine       Date:  2019-03-08       Impact factor: 5.307

4.  Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.

Authors:  Daniel F Hayes; Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; M Craig Miller; Jeri Matera; W Jeffrey Allard; Gerald V Doyle; Leon W W M Terstappen
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

Review 5.  The selectins: vascular adhesion molecules.

Authors:  T F Tedder; D A Steeber; A Chen; P Engel
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

6.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 7.  Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies.

Authors:  Ellen Heitzer; Peter Ulz; Jochen B Geigl; Michael R Speicher
Journal:  Mol Oncol       Date:  2015-12-17       Impact factor: 6.603

8.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

Review 10.  Diagnostic technologies for circulating tumour cells and exosomes.

Authors:  Huilin Shao; Jaehoon Chung; David Issadore
Journal:  Biosci Rep       Date:  2015-11-24       Impact factor: 3.840
View more
  2 in total

1.  Monte Carlo Simulations Reveal New Design Principles for Efficient Nanoradiosensitizers Based on Nanoscale Metal-Organic Frameworks.

Authors:  Ziwan Xu; Kaiyuan Ni; Jianming Mao; Taokun Luo; Wenbin Lin
Journal:  Adv Mater       Date:  2021-08-25       Impact factor: 32.086

Review 2.  Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer.

Authors:  Pedro Cruz-Nova; Alejandra Ancira-Cortez; Guillermina Ferro-Flores; Blanca Ocampo-García; Brenda Gibbens-Bandala
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.